Variant report
Variant | rs603326 |
---|---|
Chromosome Location | chr11:65556721-65556722 |
allele | C/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:65553400-65557200 | Bivalent/Poised TSS | Rectal Smooth Muscle | rectum |
2 | chr11:65554400-65556800 | Bivalent/Poised TSS | Duodenum Smooth Muscle | Duodenum |
3 | chr11:65555600-65557200 | Transcr. at gene 5' and 3' | Esophagus | oesophagus |
4 | chr11:65555800-65556800 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr11:65555800-65556800 | Active TSS | Fetal Kidney | kidney |
6 | chr11:65555800-65557000 | Bivalent Enhancer | GM12878-XiMat | blood |
7 | chr11:65555800-65558200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr11:65555800-65558800 | Weak transcription | Right Atrium | heart |
9 | chr11:65555800-65562000 | Enhancers | HMEC | breast |
10 | chr11:65556000-65558200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr11:65556000-65558600 | Enhancers | Gastric | stomach |
12 | chr11:65556000-65558800 | Weak transcription | Lung | lung |
13 | chr11:65556000-65559400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr11:65556000-65562000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
15 | chr11:65556200-65556800 | Flanking Bivalent TSS/Enh | Fetal Intestine Large | intestine |
16 | chr11:65556200-65557000 | Bivalent/Poised TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
17 | chr11:65556200-65557200 | Transcr. at gene 5' and 3' | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
18 | chr11:65556200-65557400 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
19 | chr11:65556200-65557600 | Active TSS | Colonic Mucosa | Colon |
20 | chr11:65556200-65557800 | Active TSS | Rectal Mucosa Donor 29 | rectum |
21 | chr11:65556200-65558200 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
22 | chr11:65556200-65558200 | Transcr. at gene 5' and 3' | Fetal Intestine Small | intestine |
23 | chr11:65556200-65561600 | Enhancers | Pancreas | Pancrea |
24 | chr11:65556400-65556800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
25 | chr11:65556400-65556800 | Active TSS | Duodenum Mucosa | Duodenum |
26 | chr11:65556400-65557000 | Bivalent Enhancer | iPS-20b Cell Line | embryonic stem cell |
27 | chr11:65556400-65557200 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
28 | chr11:65556400-65557200 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
29 | chr11:65556400-65557200 | Bivalent Enhancer | HepG2 | liver |
30 | chr11:65556400-65557400 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
31 | chr11:65556400-65558000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
32 | chr11:65556400-65561600 | Weak transcription | H9 Cell Line | embryonic stem cell |
33 | chr11:65556400-65561800 | Enhancers | Stomach Mucosa | stomach |
34 | chr11:65556600-65556800 | Flanking Bivalent TSS/Enh | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
35 | chr11:65556600-65557000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
36 | chr11:65556600-65557000 | Bivalent Enhancer | Small Intestine | intestine |
37 | chr11:65556600-65557400 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
38 | chr11:65556600-65558200 | Bivalent Enhancer | Placenta | Placenta |
39 | chr11:65556600-65558400 | Enhancers | H1 Cell Line | embryonic stem cell |